Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by 88STR8Ton Jun 13, 2019 6:25pm

99 Views

Post# 29824377

Experts in this

This is a great blog on the JDRF website

www.jdrf.ca/blog/sernova-recruits-first-subjects-for-its-cell-pouch-diabetes-clinical-trial/

I know that JDRF is an active partner in this clinical trial, as are the University of Chicago, CTI Clinical Trial and Consulting Services, Medtronic.....and maybe others.

I do not think Sernova could have found better partners involved in what is happening today.

Sonny, Everyone, including Sernova gets the frustration about the Canadian study and it's aftermath.... no one to blame.... too much to go around... you know what I mean ;)

Anything negative on this thread is nothing but noise.... should be ignored, and does not EVER warrant a response..... the GOOD work is underway and results are forthcoming....

ALL THE BEST IN EVERYTHING THAT IS POSITIVE...SOLDIER ON!!

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price